palbociclib,pembrolizumab
pfizer,merck
['sclc', 'keynote-091', 'pearl', 'nsclc', 'pembro']
live from #asco22: updates from pearls/keynote-091! subgroup analysis of patients with completely resected stage ib-iiia nsclc revealed that adjuvant pembrolizumab improves dfs vs placebo regardless of type of surgery, disease burden, and adjuvant chemo use. 